🇺🇸 FDA
Patent

US 9244082

Detection and treatment of LRP4-associated neurotransmission disorders

granted A61PA61P21/00A61P21/04

Quick answer

US patent 9244082 (Detection and treatment of LRP4-associated neurotransmission disorders) held by Georgia Regents Research Institute, Inc. expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Georgia Regents Research Institute, Inc.
Grant date
Tue Jan 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P21/00, A61P21/04, A61P25/00